Pyrexia, commonly known as fever, is a prevalent symptom in various clinical scenarios. It is a complex physiological response to disease, often indicating the presence of infection or inflammation. This article provides a comprehensive guide to understanding and managing pyrexia in clinical practice.
Pyrexia is a result of an altered hypothalamic set point, making the body perceive a normal temperature as suboptimal. This change is usually triggered by pyrogens, substances produced by infectious agents or released by immune cells. The body responds by increasing heat production and reducing heat loss, leading to an elevated body temperature.
Initial assessment should focus on identifying potential sources of infection or inflammation. A detailed history, physical examination, and targeted investigations are crucial. The pattern of fever can provide valuable clues. For instance, intermittent high-grade fever is characteristic of sepsis, while a low-grade fever that worsens in the evening is often seen in tuberculosis.
Management should be directed towards the underlying cause. In infectious causes, appropriate antimicrobial therapy is essential. Fever itself can be managed with antipyretics like paracetamol. However, fever is a physiological response and its suppression should be balanced against the potential benefits it offers in fighting infection.
Close monitoring of patients with pyrexia is crucial. Persistent or recurrent fever despite treatment warrants further investigation. It may indicate an uncontrolled infection, drug fever, or non-infectious causes like malignancies or autoimmune diseases. Follow-up is essential to ensure resolution of the fever and the underlying cause.
Pyrexia is a common yet complex clinical symptom. Understanding its mechanisms, careful assessment, targeted management, and vigilant monitoring are key to effective patient care. As clinicians, we must continually update our knowledge and skills in managing pyrexia to improve patient outcomes.
1.
Research uncovers hidden Australian skin cancer epidemic
2.
What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?
3.
The clinical trial of ENZAMET shows promise as a treatment for prostate cancer.
4.
Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise.
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Understanding Purpura Fulminans: Causes, Symptoms and Treatment Options
2.
The Importance of Maintaining Normal Calcium Levels in Your Body
3.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
4.
Metabolic Symbiosis Within the Tumor Niche: Mechanisms, Clinical Implications, and Therapeutic Opportunities
5.
A Comprehensive Guide to Carcinoma in Situ: Types, Risks, and Preventive Measures
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
2.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
5.
Latest Advances in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation